Kaiser Permanente and Johnson & Johnson’s corporate venturing units have helped Astute Medical, a biomarker-based medical diagnostics firm, raise $40.4m.

Kaiser Permanente and Johnson & Johnson Development Corporation were joined in the series C by venture firms MPM Capital, De Novo Ventures, Delphi Ventures and Domain Associates. Last year Astute Medical, a US-based provider of laboratory tests, extended its series B round by $13m to its existing investment consortium that included Johnson & Jonson’s corporate venturing unit.

Alongside Johnson &…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?